Back
Oramed Pharmaceuticals Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
39
ORMP
Oramed Pharmaceuticals
Last Price:
2.34
Seasonality Move:
22.85%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight buying pressure.
Oramed Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.34 | Sell |
| 20-day SMA: | 2.35 | Sell |
| 50-day SMA: | 2.38 | Sell |
| 200-day SMA: | 2.52 | Sell |
| 8-day EMA: | 2.34 | Sell |
| 20-day EMA: | 2.35 | Sell |
| 50-day EMA: | 2.37 | Sell |
| 200-day EMA: | 2.51 | Sell |
Oramed Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.77 | Sell |
| Chaikin Money Flow: | -8376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.33 - 2.39) | Sell |
| Bollinger Bands (100): | (2.32 - 2.52) | Sell |
Oramed Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oramed Pharmaceuticals Stock
Is Oramed Pharmaceuticals Stock a Buy?
- Oramed Pharmaceuticals share price is 2.33 while ORMP 8-day simple moving average is 2.34, which is a Sell signal.
- The stock price of ORMP is 2.33 while Oramed Pharmaceuticals 20-day SMA is 2.35, which makes it a Sell.
- Oramed Pharmaceuticals 50-day simple moving average is 2.38 while ORMP share price is 2.33, making it a Sell technically.
- ORMP stock price is 2.33 and Oramed Pharmaceuticals 200-day simple moving average is 2.52, creating a Sell signal.
ORMP Technical Analysis vs Fundamental Analysis
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy or a Sell?
-
Oramed Pharmaceuticals stock is rated a Sell
The current Oramed Pharmaceuticals [ORMP] share price is $2.33. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Oramed Pharmaceuticals Stock Info
Market Cap:
94.79M
Price in USD:
2.33
Share Volume:
75.38K
Oramed Pharmaceuticals 52-Week Range
52-Week High:
3.67
52-Week Low:
1.99
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Oramed Pharmaceuticals Share Price Forecast
-
What is the Oramed Pharmaceuticals stock price today?
The Oramed Pharmaceuticals stock price is 2.33 USD today. -
Will ORMP stock go up or go down?
Oramed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Oramed Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oramed Pharmaceuticals is overvalued.
Is Oramed Pharmaceuticals Stock a Buy?
- Oramed Pharmaceuticals share price is 2.33 while ORMP 8-day exponential moving average is 2.34, which is a Sell signal.
- The stock price of ORMP is 2.33 while Oramed Pharmaceuticals 20-day EMA is 2.35, which makes it a Sell.
- Oramed Pharmaceuticals 50-day exponential moving average is 2.37 while ORMP share price is 2.33, making it a Sell technically.
- ORMP stock price is 2.33 and Oramed Pharmaceuticals 200-day simple moving average is 2.51, creating a Sell signal.
Fundamental Analysis of Oramed Pharmaceuticals
Is Oramed Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Oramed Pharmaceuticals
Should I short Oramed Pharmaceuticals stock?
- ORMP Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Oramed Pharmaceuticals is a Sell
- Oramed Pharmaceuticals Relative Strength Index (RSI) is 46.77, which suggest Oramed Pharmaceuticals is oversold
- The Bollinger Bands (25) for Oramed Pharmaceuticals is (2.33 - 2.39), which suggest Oramed Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Oramed Pharmaceuticals is (2.32 - 2.52), which suggest Oramed Pharmaceuticals is a Sell
* Oramed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.